Dr. Tetsumei Urano Appointed to the World Thrombosis Day Scientific Steering Committee
May 2nd, 2016
Global Movement Welcomes Medical Expert from Japan to Steering Committee
CHAPEL HILL, NC, USA, May 2, 2016 – The World Thrombosis Day campaign, led by the International Society on Thrombosis and Haemostasis (ISTH), today announced the appointment of Dr. Tetsumei Urano, MD, PhD, to its global scientific Steering Committee. Recognized on 13 October, World Thrombosis Day focuses attention on the often overlooked and misunderstood condition of thrombosis with the goal to increase global awareness and ultimately reduce death and disability caused by the condition.
Dr. Urano is Vice President of Hamamatsu University School of Medicine in Hamamatsu, Japan. He has served as a professor of the Department of Medical Physiology at the university since 1991. He is a current council member of the Japanese Society of Thrombosis and Haemostasis and also serves as editor-in-chief of the Japanese Journal of Thrombosis and Haemostasis. In addition, Dr. Urano is a council member of the International Society of Fibrinolysis and Proteolysis.
Dr. Urano is the second representative from Japan to serve on the World Thrombosis Day Steering Committee. Dr. Yukio Ozaki represented Japan on the Steering Committee from 2014-2016. The scientific Steering Committee is comprised of leading international medical experts in the fields of hematology, thrombosis and hemostasis, vascular and general internal medicine, and public health from the United States, Canada, United Kingdom, Argentina, Germany, The Netherlands, New Zealand, Japan and Thailand.
“It is an honor to welcome Dr. Urano to the World Thrombosis Day Steering Committee,” said Dr. Gary Raskob, dean of the College of Public Health, University of Oklahoma Health Sciences Center, and chairman of the Steering Committee. “His leadership and expertise in Japan’s thrombosis and hemostasis community is an exciting and important asset to the World Thrombosis Day campaign.”
Dr. Urano received his Doctor of Medical Science from Hamamatsu University School of Medicine in Japan and completed a post-doctoral fellowship at Notre Dame University (USA). He also served as a visiting scientist for two esteemed laboratories sponsored by the Japanese government.
For more information about Dr. Urano and the World Thrombosis Day campaign, visit www.worldthrombosisday.org.
About World Thrombosis Day
Launched in 2014 and held annually on 13 October, World Thrombosis Day (WTD) aims to increase public, healthcare professional and health care systems’ awareness of thrombosis and, ultimately, to reduce deaths and disabilities from thromboembolic disease through a greater awareness of its causes, risk factors, signs and symptoms, and evidence-based prevention and treatment. WTD’s mission supports the World Health Assembly's global target of reducing premature deaths by non-communicable disease by 25 percent by 2025, as well as the WHO global action plan for the prevention and control of non-communicable diseases in the 2013-2020 timeframe. Unrestricted corporate grants to help support WTD come from founding global partner Bayer HealthCare; global partners are Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer Alliance, Daiichi Sankyo, Medtronic, Janssen and Portola Pharmaceuticals. Visit www.worldthrombosisday.org for more information.
About the ISTH
Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. ISTH is an international professional membership organization with 4,000 clinicians, researchers and educators working together to improve the lives of patients in more than 93 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs such as its Core Curriculum, research activities; meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Visit ISTH online at www.isth.org.
Barbara Krolak, Relationship and Campaign Specialist
International Society on Thrombosis and Haemostasis